IMPACT OF MORPHINE USE ON MORTALITY IN STEMI PATIENTS TREATED WITH PRIMARY PCI

Morphine (MO) decreases the effect of P2Y12 receptor inhibitors in vitro and observational reports suggest that its use is associated with larger infarct size. Yet, there are few data available about the impact of this interaction on clinical outcomes. We studied the effect of MO on mortality in